Growing Demand for Paranasal Sinus Cancer Market to Significantly Increase Revenues Through 2027
Market
Overview
Paranasal Sinus Cancer Market Research Report –
Global Forecast till 2023 Research Future (MRFR) estimates the global
paranasal sinus cancer market to garner a CAGR of 5.2% during the assessment
period of 2018–2023.
Paranasal sinus
cancer is an extremely rare case of cancer
in which cells of the paranasal sinuses
and nasal cavity develop malignancy. Dust and certain chemical agents in the
air can cause paranasal sinuses cancer. Increase in air pollution and growing
prevalence of chronic disease among people can spur the risk of developing
paranasal sinuses cancer.
These factors can
fuel the paranasal sinus cancer market. The rise in geriatric population is
another factor identified to boost the market growth. According to the American
Cancer Society, 4 out of 5 paranasal sinus cancer cases are of atleast 55 years
old. Collaboration strategies can have
powerful impact on the market growth. For example, in 2018, development and
marketing of digital clinical decision support solutions, was the outcome of G
E Healthcare’s partnership with Roche
Diagnostics. In June 2018,
ARMO Biosciences
was taken over by Eli Lilly for USD 1.6 billion for expanding its oncology
portfolio that backed support for its oncology portfolio. Hence, these
instances demonstrate that collaborations can create immense scope for new
innovation. Therefore, new product launches is a significant cause that can
bolster the paranasal
sinus cancer market growth.
Expensive
treatment for paranasal sinus cancer and strict rules governing new product
approval are certain causes which can restraint the market growth.
Segments Analysis
MRFR’s segmental
analysis of the paranasal sinus cancer offers a comprehensive insight into the
market that allows our esteemed clients to develop growth strategies,
identifying new scope for the market expansion. The global paranasal sinus
cancer market study has been segmented into diagnosis, treatment, and end user.
Based on the
diagnosis, the market study has been segmented into physical examination, imaging tests,
biopsy, medical history, and others. The
imaging tests segment has been further classified into X-rays, CT scan, MRI scan,
and PET scan. The biopsy segment is sub-segmented into fine needle aspiration
(FNA) biopsy, and incisional and excisional biopsies.
Based on the
treatment, the market study has been segmented into radiotherapy, surgery, and
chemotherapy.
Based on the end
user, the market study has been segmented into hospitals and clinics, research
laboratories, cancer treatment and research centers, and others.
Regional Insights
A vivid understanding of the regional
paranasal sinus cancer market activities can be derived from the regional
analysis of the market. Based on the region, the market has been segmented into
America, Europe, Asia Pacific, and the Middle East.
The North American paranasal sinus
cancer market is expected to be at the forefront owing to the increase in rare
cancer and chronic disease cases in the region. Excellent medical
infrastructure and increase in medical expenses are other factors which can
amplify the regional market growth.
Increase in cases of people suffering
from chronic diseases, government funding, and firm medical infrastructure in
Europe, the paranasal sinus cancer market is anticipated to exhibit a robust
growth, securing the second largest market size in the near future.
Government in the Asia Pacific region
are keen in taking initiatives to improve healthcare facilities which is
predicted as a major cause that can propel the regional market. hike in
disposable income and growing prevalence of chronic diseases are other factors
which can fuel the regional paranasal sinus cancer market growth.
MRFR predicts that the paranasal sinus
cancer market in the Middle East Asia and Africa is expected to exhibit static
market growth.
Browse
Complete Report Details @ https://www.marketresearchfuture.com/reports/paranasal-sinus-cancer-market-7514
Key
Players
Important companies operating in the
market are AbbVie,
Inc., Pfizer Inc., Eli Lilly & Company, Novartis AG, Ipsen
Biopharmaceuticals Inc, G E Healthcare, Agilent Technologies Inc., AstraZeneca,
Boehringer Ingelheim International GmbH,
Bristol-Myers Squibb Company, F. Hoffman-La Roche Ltd., Abbott, Becton,
Dickinson & Company, Thermo
Fisher Scientific, and Bayer AG.
NOTE: Our Team of Researchers are
Studying Covid19 and its Impact on Various Industry Verticals and wherever
required we will be considering Covid19 Footprints for Better Analysis of
Market and Industries. Cordially get in Touch for More Details.
Comments
Post a Comment